These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 33153990)

  • 21. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
    Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
    Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
    O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
    Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of health-related quality of life in patients with interstitial lung disease.
    Chang JA; Curtis JR; Patrick DL; Raghu G
    Chest; 1999 Nov; 116(5):1175-82. PubMed ID: 10559073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis.
    Capparelli I; Fernandez M; Saadia Otero M; Steimberg J; Brassesco M; Campobasso A; Palacios S; Caro F; Alberti ML; Rabinovich RA; Paulin F
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):68-73. PubMed ID: 29102341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial lung diseases specific measures in exercise interventions: A systematic review of measurement properties.
    Oliveira A; Habash R; Ellerton L; Maybank A; Alsubheen S; Marques A; Goldstein R; Brooks D
    Ann Phys Rehabil Med; 2023 Feb; 66(1):101682. PubMed ID: 35659584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study.
    Akihiko S; Tomohiro H; Toru O; Kiminobu T; Kohei I; Yoshinari N; Takeshi K; Kumiko K; Kazuo C; Michiaki M
    Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(3):226-235. PubMed ID: 32476850
    [No Abstract]   [Full Text] [Related]  

  • 28. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
    Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
    Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and impact of airway diseases on clinical outcomes in idiopathic pulmonary fibrosis.
    Park H; Cho J; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Choi SM
    Korean J Intern Med; 2022 Mar; 37(2):387-397. PubMed ID: 34865413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates.
    Hoyer N; Prior TS; Bendstrup E; Shaker SB
    BMJ Open Respir Res; 2022 Jul; 9(1):. PubMed ID: 35798532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
    Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D
    Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The King's Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference.
    Sinha A; Patel AS; Siegert RJ; Bajwah S; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    BMJ Open Respir Res; 2019; 6(1):e000363. PubMed ID: 30956799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study.
    Janssen K; Rosielle D; Wang Q; Kim HJ
    Respir Res; 2020 Jan; 21(1):2. PubMed ID: 31900187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
    Wu Q; Zhou Y; Feng FC; Zhou XM
    Chin J Integr Med; 2019 Oct; 25(10):778-784. PubMed ID: 29335860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study.
    Wapenaar M; Bendstrup E; Molina-Molina M; Stessel MKN; Huremovic J; Bakker EW; Kardys I; Aerts JGJV; Wijsenbeek MS
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):192-202. PubMed ID: 33093783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
    Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial Pneumonia.
    Kirsten D; de Vries U; Costabel U; Koschel D; Bonella F; Günther A; Behr J; Claussen M; Schwarz S; Prasse A; Kreuter M
    Pneumologie; 2022 Jan; 76(1):25-34. PubMed ID: 34521147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Ogawa T; Watanabe F; Nishimura K
    Respir Med; 2005 Apr; 99(4):408-14. PubMed ID: 15763446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort.
    Cottin V; Gueguen S; Jouneau S; Nunes H; Crestani B; Bonniaud P; Wémeau-Stervinou L; Reynaud-Gaubert M; Israël-Biet D; Cadranel J; Marchand-Adam S; Quétant S; Hirschi S; Montani D; Gamez AS; Chevereau M; Dufaure-Garé I; Amselem S; Clement A;
    Respiration; 2022; 101(1):34-45. PubMed ID: 34515219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis.
    Kim JW; Clark A; Birring SS; Atkins C; Whyte M; Wilson AM
    Chron Respir Dis; 2021; 18():14799731211033925. PubMed ID: 34609156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.